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Abstract
Introduction: Hypercalcemia is a complication often seen in chronic hemodialysis patients. A rare
cause of this condition is sarcoidosis. Its highly variable clinical presentation is challenging. Especially
in patients suffering chronic kidney graft failure the nonspecific constitutional symptoms of
sarcoidosis like fever, weight loss, arthralgia and fatigue may be easily misleading.
Case presentation: A 51 year old male developed hypercalcemia, arthralgia and B-symptoms
after explantation of his kidney graft because of suspected acute rejection. The removed kidney
showed vasculopathy and tubulointerstitial nephritis, which had not been overt in the biopsy taken
half a year earlier. Despite explantation and withdrawal of the immunosuppression the patient's
general condition deteriorated progressively. A rapid rise in serum calcium finally provoked us to
check for sarcoidosis. CT scans of the lungs, broncho-alveolar-lavage and further lab tests
confirmed the diagnosis.
Conclusion: This case demonstrates that withdrawal of immunosuppressive drugs sometimes
unmasks sarcoidosis. It should be considered as differential diagnosis even in hemodialysis patients,
in whom other reasons for hypercalcemia are much more common.
Introduction
Hypercalcemia is a complication often seen in chronic
hemodialysis patients. In these patients various circum-
stances can cause a high serum calcium level. Most of
them can be detected easily like a tertiary hyperparathyre-
oidism, the use of 1α-hydroxylated vitamin D metabo-
lites, the inappropriate medication with calcium
phosphate binders or the use of a high dialysate calcium
[1].
The challenge for the physician is to recognize the rare
causes of hypercalcemia in hemodialysis patients such as
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sis as an example of granulomatous diseases.
Knowing that symptomatic sarcoidosis is usually treated
with immunosuppressive drugs [2], it is easy to under-
stand that the withdrawal of immunosuppression in
transplanted patients no longer prevents the "de novo"
development or the recurrence of sarcoidosis. Up to date
literature counts only very few cases of sarcoidosis appear-
ing shortly after withdrawal of immunosuppressive regi-
men, all of them recurrent forms of sarcoidosis [3-8]. In
contrast to these reports, our case describes most likely a
"de novo" sarcoidosis already appearing after reduction of
the immunosuppressive regimen.
Case presentation
A 51-year-old man developed end-stage renal failure due
to biopsy proven IgA nephritis. He started hemodialysis in
April 1977. 1980, 1985 and 1997 he received cadaveric
kidney transplantation. In 1998 a parathyreoidectomy
was performed because of a severe tertiary hyperparathy-
reoidism. From 1997 to November 2003 the patient did
not need dialysis. In December 2003 hemodialysis was
started again due to declining kidney function. Transplant
biopsy rendered chronic transplant vasculopathy. The
graft remained in situ to preserve residual diuresis. The
immunosuppressive regimen was reduced to 5 mg pred-
nisone and 50 mg azathioprine per day until October
2004. From this point onwards only 5 mg prednisone per
day was given. In June 2005 the patient presented with an
inflammatory syndrome with slightly elevated body tem-
perature (up to 37.5°Celsius) and a general weakness of
the body. To rule out acute rejection the patient under-
went another transplant biopsy which besides the known
transplant vasculopathy revealed tubulointerstitial
nephritis as a new finding. This was interpreted as acute
rejection, the graft was removed (end of June 2005) and
immunosuppression was completely withdrawn. A few
days after a moderate fever reappeared. The patient com-
plained about testicular pain. Ultrasound showed a pic-
ture resembling epididymitis. An empiric treatment with
ciprofloxacin did neither alleviate the complaints nor the
ultrasound aspects of the enlarged epididymis. In the fol-
lowing weeks the patient's general condition deteriorated
progressively. He complained about insomnia and strong
pruritus. This was accompanied by unwanted loss of 4 kg
body weight within 12 weeks. Alternating arthralgia was
the most bothering symptom. X-rays and ultrasound
examinations of the affected joints ruled out specific affec-
tions or diseases of the bones. Laboratory tests showed a
rapidly increasing serum calcium: 2.84 mmol/l (normal
value: 2.2–2.65 mmol/l), (fig. 1) despite normal or only
moderately elevated serum levels of parathyroid hormone
(PTH) (PTH intact: 1.2–4.5 pmol/l). Serum alkaline phos-
phatase was elevated with a level of 173 U/l (normal
value: 35–104 U/l). C-reactive protein was only moder-
ately elevated (fig. 2). We changed the patient to a low cal-
cium dialysate concentration and to the phosphate binder
sevelamer. Vitamin D substitution had been stopped
more than three months before. Despite all these meas-
ures the high serum calcium level and the clinical symp-
toms remained unchanged.
Finally the persisting hypercalcemia provoked us to check
for sarcoidosis. Indeed X-rays of the thorax revealed a
pathological hilus configuration. A thoracic CT scan
Serum C-reactive proteinFig re 2
Course of c-reactive protein (mg/l)
Serum calcium levelFig re 1
Course of serum calcium (mmol/l). Arrow 1: reduction of 
immunosuppression to 5 mg prednisolone per day. Arrow 2: 
complete stop of immunosuppression. Arrow 3: restart of 
prednisolon 50 mg per day.Page 2 of 5
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cm in diameter and a disseminated, micronodulary
shaped densities of both lungs (Fig. 3 and 4).
A transbronchial biopsy rendered only chronic-atrophic
bronchitis. But broncho-alveolar lavage (BAL) revealed a
CD4/CD8 ratio above the normal value. The diagnosis
sarcoidosis was strengthened by further lab tests: Angi-
otensin-converting enzyme level: 158 U/l (normal value:
20–60 U/l). Soluble Interleukin2 receptor: 4133 U/ml
(normal value: 220–710 U/ml) were elevated. We also
found high levels for lysozyme, but no sign of a serum
hypergammaglobulinaemia.
With the suspected diagnosis of sarcoidosis we decided to
administer prednisone at a dose of 50 mg/day for 3 weeks.
In the following time the dose was tapered 2.5 mg every
week up to a permanent dose of 5 mg/day. In a short time
the patient's general condition improved tremendously.
Within a few days the body temperature returned to nor-
mal values and pain, anorexia and pruritus disappeared.
Serum calcium values returned to normal levels (Fig. 1).
The suppressed PTH intact level found back to normal val-
ues within 8 weeks. Serum alkaline phosphatase and angi-
otensin converting enzyme returned to normal under
steroid therapy: AP: 79 U/l, normal: 35–104 U/l, ACE: 54
U/L, normal: 20–60 U/l. In a CT scan in April 2006 the
micronodulary alterations of both lungs were no longer
seen. Number and size of the affected mediastinal lymph-
nodes were markedly reduced.
Bodyplethysmography still showed a restrictive alteration.
We administered an inhalative salmeterol-fluticason com-
bination. In April 2006 the pulmonary function was com-
pletely intact. No signs of restriction or obstruction were
found in the tests.
For more than one year the patient is now without clinical
and biological symptoms taking 5 mg alternating 2.5 mg
prednisone per day.
Conclusion
Sarcoidosis is a multisystem disorder of unknown etiol-
ogy characterized by the accumulation of lymphocytes,
mononuclear phagocytes and non-caseating granuloma
in involved tissues [9]. Due to the frequency of pulmonary
involvement bronchoscopy is an important diagnostic
tool. Bronchoscopy enables the investigator to identify
endobronchial lesions, which can be found in almost half
of the cases [10]. In our patient tissue biopsy did not show
signs of sarcoidosis, but broncho-alveolar lavage rendered
a lymphocytic alveolitis with a CD4/CD8-ratio (>3.5)
which is highly consistent with sarcoidosis. The sensitivity
of CD4/CD8-ratio ranges from 42 to 59% and specificity
from 76–96% [10]. Furthermore, it can be speculated if
the tubulointerstitial nephritis was a sign of renal involve-
Computed tomography of the chest (II)Figure 4
Computed tomography of the chest (II). CT of the chest: 
Nodular and reticular interstitial lung involvement.
Computed tomography of the chest (I)Figure 3
Computed tomography of the chest (I). CT of the chest: Dis-
tinct mediastinal (large arrow) and perihilar lymphadenopa-
thy (small arrow)Page 3 of 5
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incidence of sarcoidosis kidney disease is hard to define.
Notably granulomatous interstitial nephritis accounts
only for 10–15% of renal involvement. Interstitial nephri-
tis without granuloma has been described but seems
much less common [11]. In our case histology showed
significant interstitial infiltration, moderate tubulitis and
intimal arteriitis. Glomeruli had a normal morphology
and no granulomata were found. Altogether, sarcoidosis
cannot be ruled out, but sarcoid interstitial nephritis with-
out granulomata is reported to be very rare, so that rejec-
tion seems to be more likely in our patient. However, the
assumed epididymitis was probably a sarcoid lesion. In an
autopsy series, 5% of cases had genital involvement (most
frequently of the epididymis), with bilateral disease
present in approximately one-third of them. It is often
asymptomatic, but patients may also present with a scro-
tal mass or pain. Testicular granulomata are much less
common [12]. Finally it was only the synopsis of the clin-
ical manifestations, the pathologic lab tests (hypercal-
cemia, ACE, IL-2-Receptor, lysozyme) and finally the
response to treatment with steroids which allowed to con-
firm the diagnosis.
Our patient received an immunosuppressive treatment for
a long time and retrospectively it is difficult to say whether
sarcoidosis came up "de novo" after withdrawal of azathi-
oprin and prednisone or if it was reactivated. IgA neph-
ropathy was reason for end stage renal disease in our
patient thirty years ago. The association of sarcoidosis and
IgA glomerulonephritis is uncommon but has been
reported [13]. Unfortunately we had no possibility to re-
examine the patient's initial renal biopsy to look for typi-
cal signs of sarcoidosis. Neither the patient's history offers
any signs for sarcoidosis before, nor did a pulmonary CT
scan three years earlier. Thus we assume that sarcoidosis
developed "de novo" after reduction of the immunosup-
pressive regimen and was finally aggravated when the
medication was stopped completely. There are only a few
reports describing sarcoidosis in kidney graft recipients
after withdrawal of immunosuppression (see Table 1).
The spectrum of clinical presentation is highly various
and reached from high fevers, neurologic symptoms, graft
failure and lung involvement including pleural effusion
[3-7]. Distinct hypercalcemia was only reported in two
patients. That should remind us, that many cases do not
present with massive hypercalcemia. A calcium level in
the upper normal range or slightly above that should also
catch our attention. In patients with end stage renal dis-
ease tertiary hyperparathyreoidism, the use of vitamin D
metabolites, calcium phosphate binders or high dialysate
calcium are frequent causes of hypercalcemia and should
be considered first. Further workup should follow a stand-
ardized regimen, like the one proposed by Carroll and col-
leagues [14]. Noteworthy, all patients developed most
likely a reactivation of sarcoidosis. In every case sarcoido-
sis occurred either after steroids have been tapered or in a
patient receiving a steroid-free immunosuppressive regi-
men from beginning. This underlines the important role
of steroids in the treatment of sarcoidosis. Hypercalcemia
and the severity of clinical symptoms provoked us to ini-
tiate systemic treatment using prednisone immediately.
Various theories of the pathogenesis (infection, hypersen-
sitivity and autoimmunity) exist. Sarcoidosis may result
from an exposure to an antigen in a genetically predis-
posed, susceptible host [2,11]. When therapy is required,
corticosteroids are considered standard [15]. Studies dem-
onstrating their ability to modify the long-term outcome
in this disease are still lacking. Often, the adverse side
effects of corticosteroids necessitate the addition of other
immunomodulating substances [15]. Our patient
remained on low-dose steroids without any clinical symp-
toms more that one year after diagnosis. This case demon-
strates that withdrawal of immunosuppressive drugs
sometimes unmasks sarcoidosis. It stresses the diagnostic
difficulties of sarcoidosis due to its highly variable clinical
presentation. Moreover, it reminds every nephrologist to
consider sarcoidosis as a differential diagnosis even in
hemodialysis patients, in whom other reasons for hyper-
calcemia are much more common.
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Table 1: Cases reporting sarcoidosis after reduction of immunosuppression
Shen et al. Am J Med. 1986 Apr;80(4):699–702. Reactivation of sarcoidosis in kidney graft [7]
Brown et al. Nephrol Dial Transplant. 1992;7(2):173. Reactivation after transplantation (steroid-free 
immunosuppressive regimen)
[3]
Herrero et al. Nephrol Dial Transplant. 1998 
Dec;13(12):3280–1.
Reactivation in kidney graft after steroid withdrawal, 
Hypercalcemia
[4]
Schmidt et al. Transplantation. 1999 Nov 15;68(9):1420–3 Reactivation after steroid withdrawal (lung, pleura), 
Hypercalcemia
[6]
Kukura et al. Nephrol Dial Transplant (2004) 19: 1640–1642 Reactivation in graft after steroid withdrawal (during 
pregnancy)
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